Article
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.
Blood cancer journal - 14 Aug 2025
Harris Ethan J, Karaoglu Diren Arda, Sukhanova Madina, Abaza Yasmin, Karantanos Theodoros, Eisfeld Ann-Kathrin, Anderson Clare, Lin Chenyu, Moreno Vanegas Yenny A, Badar Talha, Coltoff Alexander, Knepper Todd C, Ozkaya Neval, Youshanlouei Hamed Rahmani, Cetin Sinan, Patel Anand A, DuVall Adam S, Drazer Michael W, Wang Peng, Tjota Melissa, Segal Jeremy P, Venkataraman Girish, Gurbuxani Sandeep, Cheng Jason X, Arber Daniel A, Larson Richard A, Odenike Olatoyosi, Webster Jonathan, Shah Bijal, Stock Wendy, Saygin Caner
Abstract excerpt
TP53-mutant acute lymphoblastic leukemia (ALL) in adults is a high-risk subtype with poor outcomes, yet its molecular landscape and clinical implications remain incompletely defined. In this multi-institutional study of 830 adult ALL patients treated at eight academic centers between 2010 and 2024, we demonstrated that TP53 mutations are independent predictors of inferior overall survival in both B-ALL (median,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
